|
|
| | Arimoclomol citrate Basic information |
| | Arimoclomol citrate Chemical Properties |
| form | Solid | | color | White to off-white |
| | Arimoclomol citrate Usage And Synthesis |
| Uses | Arimoclomol is a co-inducer of HSP that acts through heat shock factor 1 (HSF1) in cells undergoing cellular stress. Has therapeutic potential in motor neuron degenerative diseases. Potential treatment for liposomal storage disorders, such as Niemann-Pick disease type C. | | in vivo | Arimoclomol (BRX-220; 20 mg/kg; orally administered for 5 d) has a protective effect against cholecystokinin-octapeptide (CCK)-induced acute pancreatitis[1]. | Animal Model: | Male Wistar rats weighing 240 to 270 g[1] | | Dosage: | 20 mg/kg | | Administration: | Administered intragastrically, for 5 days | | Result: | Had a protective effect against CCK-induced acute pancreatitis. |
| | IC 50 | HSP |
| | Arimoclomol citrate Preparation Products And Raw materials |
|